Extensible open-source zero-footprint web viewer for oncologic imaging research

用于肿瘤成像研究的可扩展开源零足迹 Web 查看器

基本信息

  • 批准号:
    9324177
  • 负责人:
  • 金额:
    $ 65.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-15 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by principal investigator): Managing the increasingly complex workflow and imaging analyses for oncology clinical trials to provide timely, protocol-compliant assessments requires sophisticated informatics tools. To address these issues, over the past 10 years the Tumor Imaging Metrics Core (TIMC), a CCSG Shared-Resource of the Dana-Farber/Harvard Cancer Center (DF/HCC), has developed a software informatics system for managing the workflow and image measurements for oncology clinical trials. This system currently is in use across the 5 DF/HCC Harvard hospitals to manage over 600 active clinical trials, with 800 users, and has been licensed and implemented at several other Cancer Centers, including Yale, Utah/Huntsman Cancer Institute, and UW/Seattle Cancer Care Alliance. The workflow management informatics system includes a web-application/database for protocol registration, order entry, work list management, reporting, and billing/administrative functions. However, the integrated, open-source image analysis platform is workstation-based and needs to be installed and updated on each computer where imaging measurements will be performed. Thus, the open- source imaging system is a limiting factor in deployment, requiring added IT desktop support and maintenance at each location where imaging assessments will be performed. The widespread adoption of this system across NCI Cancer Centers will be aided and facilitated by adapting the image analysis functionality into a web-based open-source platform. The current proposal is to 1) create a vendor-neutral, open-source, extensible, zero-footprint web-viewer and supporting server for display and analysis of DICOM images, and 2) create a plug-in architecture to allow us to replace our current open-source image workstation with this zero-footprint web-viewer for our TIMC clinical trials management system. In order to make the system broadly available to the oncology research community, in addition to developing an interface to our TIMC web-application, we will also implement an AIM (Annotation and Image Markup) interface so that caBIG investigators and other AIM framework research projects can integrate easily with our web-viewer. The viewer will meet all of the basic requirements for radiology tumor measurements specific to the needs of oncology clinical trials, yet also be flexible enough to be configured for user preferences and extended via plug-ins to support varied research workflows as a shared research resource. To achieve these design goals, the viewer and all of its functionality will be delivered to client machines exclusively through the web browser with nothing to install on client computers or mobile devices, which greatly simplifies and reduces the cost and support requirements of software deployments, and increases accessibility. The proposed viewer will enable researchers, imaging software developers, clinicians, and patients to access oncology clinical trials images in a freely availabl and openly extensible environment. This will facilitate remote image viewing and collaborative image consultations among a wide-range of imaging professionals. The web-DICOM viewer will be fully integrated with the TIMC clinical trials informatics management system so that both systems can be deployed across NCI Cancer Centers in a completely web-based implementation without desktop IT support. An AIM interface will also be provided so that the web-viewer can be integrated broadly across the caBIG/AIM cancer research community.
 描述(由主要研究者提供):管理肿瘤临床试验日益复杂的工作流程和成像分析,以提供及时、符合方案的评估,需要复杂的信息学工具。为了解决这些问题,在过去的10年中,肿瘤成像核心(TIMC),丹娜-法伯/哈佛癌症中心(DF/HCC)的CCSG共享资源,已经开发了一个软件信息系统,用于管理肿瘤临床试验的工作流程和图像测量。该系统目前在5家DF/HCC哈佛医院使用,管理超过600项活跃的临床试验,有800名用户,并已在其他几个癌症中心获得许可和实施,包括耶鲁大学、犹他州/亨茨曼癌症研究所和华盛顿大学/西雅图癌症护理联盟。工作流管理信息系统包括用于方案注册、订单输入、工作列表管理、报告和计费/管理功能的网络应用程序/数据库。然而,集成的开源图像分析平台是基于工作站的,需要在执行成像测量的每台计算机上安装和更新。因此,开放源码成像系统是部署中的一个限制因素,需要在将执行成像评估的每个位置增加IT桌面支持和维护。通过将图像分析功能调整为基于网络的开源平台,将有助于在NCI癌症中心广泛采用该系统。目前的建议是:1)创建一个供应商中立的、开源的、可扩展的、零占用空间的网络查看器和支持服务器,用于显示和分析DICOM图像; 2)创建一个插件架构,允许我们使用TIMC临床试验管理系统的零占用空间网络查看器替换当前的开源图像工作站。为了使该系统广泛提供给肿瘤学研究界,除了开发一个接口到我们的TIMC网络应用程序,我们还将实现一个AIM(注释和图像标记)接口,使caBIG研究人员和其他AIM框架研究项目可以很容易地与我们的网络浏览器集成。该查看器将满足肿瘤临床试验特定需求的放射肿瘤测量的所有基本要求,但也足够灵活,可以根据用户偏好进行配置,并通过插件进行扩展,以支持作为共享研究资源的各种研究工作流程。为了实现这些设计目标,查看器及其所有功能将仅通过Web浏览器交付给客户端计算机,而无需在客户端计算机或移动的设备上安装任何东西,这大大简化并降低了软件部署的成本和支持要求,并提高了可访问性。拟议的观众将使研究人员,成像软件开发人员,临床医生和患者访问肿瘤临床试验图像在一个免费提供和开放的可扩展的环境。这将促进远程图像查看和协作图像咨询之间的广泛的成像专业人员。网络DICOM查看器将与TIMC临床试验信息管理系统完全集成,以便这两个系统可以在没有桌面IT支持的情况下以完全基于网络的实施方式在NCI癌症中心部署。还将提供一个AIM界面,以便网络查看器可以广泛地集成到整个caBIG/AIM癌症研究社区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GORDON J HARRIS其他文献

GORDON J HARRIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GORDON J HARRIS', 18)}}的其他基金

Extensible Open Source Zero-Footprint Web Viewer for Cancer Imaging Research
用于癌症成像研究的可扩展开源零足迹 Web 查看器
  • 批准号:
    10644112
  • 财政年份:
    2023
  • 资助金额:
    $ 65.52万
  • 项目类别:
Lymph Node Quantification System for Multisite Clinical Trials
用于多站点临床试验的淋巴结定量系统
  • 批准号:
    10687096
  • 财政年份:
    2019
  • 资助金额:
    $ 65.52万
  • 项目类别:
Neuroimaging Core
神经影像核心
  • 批准号:
    7141470
  • 财政年份:
    2006
  • 资助金额:
    $ 65.52万
  • 项目类别:
Tumor Imaging Metrics Core
肿瘤成像指标核心
  • 批准号:
    10332584
  • 财政年份:
    1997
  • 资助金额:
    $ 65.52万
  • 项目类别:
Tumor Imaging Metrics Core
肿瘤成像指标核心
  • 批准号:
    10540443
  • 财政年份:
    1997
  • 资助金额:
    $ 65.52万
  • 项目类别:
Core 03: Tumor Imaging Metrics
核心 03:肿瘤成像指标
  • 批准号:
    10062885
  • 财政年份:
    1997
  • 资助金额:
    $ 65.52万
  • 项目类别:
NEUROIMAGING IN PERSONS AT RISK FOR HUNTINGTON'S DISEASE
亨廷顿氏病高危人群的神经影像学检查
  • 批准号:
    2333004
  • 财政年份:
    1994
  • 资助金额:
    $ 65.52万
  • 项目类别:
NEUROIMAGING IN PERSONS AT RISK FOR HUNTINGTON'S DISEASE
亨廷顿氏病高危人群的神经影像学检查
  • 批准号:
    2272196
  • 财政年份:
    1994
  • 资助金额:
    $ 65.52万
  • 项目类别:
NEUROIMAGING IN PERSONS AT RISK FOR HUNTINGTON'S DISEASE
亨廷顿氏病高危人群的神经影像学检查
  • 批准号:
    2272197
  • 财政年份:
    1994
  • 资助金额:
    $ 65.52万
  • 项目类别:
NEUROIMAGING IN PERSONS AT RISK FOR HUNTINGTON'S DISEASE
亨廷顿氏病高危人群的神经影像学检查
  • 批准号:
    2272198
  • 财政年份:
    1994
  • 资助金额:
    $ 65.52万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 65.52万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 65.52万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 65.52万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 65.52万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了